35 related articles for article (PubMed ID: 26673797)
1. Measuring the Invisible: Circulating Tumor DNA as a Predictive and Prognostic Marker of Response to Adjuvant Chemotherapy in Resected Colorectal Cancer.
D'Arienzo PD; Pinato DJ
Gastroenterology; 2023 Nov; 165(5):1303-1304. PubMed ID: 37329960
[No Abstract] [Full Text] [Related]
2. Author Correction: Evaluation of cell surface vimentin positive circulating tumor cells as a prognostic biomarker for stage III/IV colorectal cancer.
Yu J; Yang M; Peng T; Liu Y; Cao Y
Sci Rep; 2024 Mar; 14(1):6449. PubMed ID: 38499580
[No Abstract] [Full Text] [Related]
3. Heterogeneity and versatility of the extracellular matrix during the transition from pleomorphic adenoma to carcinoma ex pleomorphic adenoma: cumulative findings from basic research and new insights.
Scarini JF; de Lima-Souza RA; Lavareze L; Ribeiro de Assis MCF; Damas II; Altemani A; Egal ESA; Dos Santos JN; Bello IO; Mariano FV
Front Oral Health; 2023; 4():942604. PubMed ID: 37138857
[TBL] [Abstract][Full Text] [Related]
4. ECM Substrates Impact RNAi Localization at Adherens Junctions of Colon Epithelial Cells.
Daulagala AC; Kourtidis A
Cells; 2022 Nov; 11(23):. PubMed ID: 36497003
[TBL] [Abstract][Full Text] [Related]
5. Collagen Family as Promising Biomarkers and Therapeutic Targets in Cancer.
Necula L; Matei L; Dragu D; Pitica I; Neagu A; Bleotu C; Diaconu CC; Chivu-Economescu M
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293285
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the extracellular matrix by Streptococcus gallolyticus subsp. gallolyticus and importance in cell proliferation.
Kumar R; Taylor JC; Jain A; Jung SY; Garza V; Xu Y
PLoS Pathog; 2022 Oct; 18(10):e1010894. PubMed ID: 36191045
[TBL] [Abstract][Full Text] [Related]
7. The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?
Jurj A; Ionescu C; Berindan-Neagoe I; Braicu C
J Exp Clin Cancer Res; 2022 Sep; 41(1):276. PubMed ID: 36114508
[TBL] [Abstract][Full Text] [Related]
8. Type IV Collagen in Human Colorectal Liver Metastases-Cellular Origin and a Circulating Biomarker.
Lindgren M; Rask G; Jonsson J; Berglund A; Lundin C; Jonsson P; Ljuslinder I; Nyström H
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884455
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Stromal Type IV Collagen Expression in Small Invasive Breast Cancers.
Jansson M; Lindberg J; Rask G; Svensson J; Billing O; Nazemroaya A; Berglund A; Wärnberg F; Sund M
Front Mol Biosci; 2022; 9():904526. PubMed ID: 35693557
[TBL] [Abstract][Full Text] [Related]
10. Decreased m6A Modification of CD34/CD276(B7-H3) Leads to Immune Escape in Colon Cancer.
Zhou Y; Zhou H; Shi J; Guan A; Zhu Y; Hou Z; Li R
Front Cell Dev Biol; 2021; 9():715674. PubMed ID: 34307389
[TBL] [Abstract][Full Text] [Related]
11. Type IV collagen as a potential biomarker of metastatic breast cancer.
Lindgren M; Jansson M; Tavelin B; Dirix L; Vermeulen P; Nyström H
Clin Exp Metastasis; 2021 Apr; 38(2):175-185. PubMed ID: 33655422
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of blood-based fibrosis biomarkers in patients with metastatic colorectal cancer receiving chemotherapy and bevacizumab.
Nissen NI; Kehlet S; Boisen MK; Liljefors M; Jensen C; Johansen AZ; Johansen JS; Erler JT; Karsdal M; Mortensen JH; Høye A; Willumsen N
Sci Rep; 2021 Jan; 11(1):865. PubMed ID: 33441622
[TBL] [Abstract][Full Text] [Related]
13. GBM-Targeted oHSV Armed with Matrix Metalloproteinase 9 Enhances Anti-tumor Activity and Animal Survival.
Sette P; Amankulor N; Li A; Marzulli M; Leronni D; Zhang M; Goins WF; Kaur B; Bolyard C; Cripe TP; Yu J; Chiocca EA; Glorioso JC; Grandi P
Mol Ther Oncolytics; 2019 Dec; 15():214-222. PubMed ID: 31890868
[TBL] [Abstract][Full Text] [Related]
14. The role of collagen in cancer: from bench to bedside.
Xu S; Xu H; Wang W; Li S; Li H; Li T; Zhang W; Yu X; Liu L
J Transl Med; 2019 Sep; 17(1):309. PubMed ID: 31521169
[TBL] [Abstract][Full Text] [Related]
15. Tissue Inhibitor of Metalloproteinase-1 Is Confined to Tumor-Associated Myofibroblasts and Is Increased With Progression in Gastric Adenocarcinoma.
Alpízar-Alpízar W; Laerum OD; Christensen IJ; Ovrebo K; Skarstein A; Høyer-Hansen G; Ploug M; Illemann M
J Histochem Cytochem; 2016 Aug; 64(8):483-94. PubMed ID: 27370797
[TBL] [Abstract][Full Text] [Related]
16. The Prognostic and Predictive Value of Soluble Type IV Collagen in Colorectal Cancer: A Retrospective Multicenter Study.
Rolff HC; Christensen IJ; Vainer B; Svendsen LB; Eefsen RL; Wilhelmsen M; Lund IK; Høyer-Hansen G; Nielsen HJ; Illemann M;
Clin Cancer Res; 2016 May; 22(10):2427-34. PubMed ID: 26673797
[TBL] [Abstract][Full Text] [Related]
17. LGR5 and CD133 as prognostic and predictive markers for fluoropyrimidine-based adjuvant chemotherapy in colorectal cancer.
Stanisavljević L; Myklebust MP; Leh S; Dahl O
Acta Oncol; 2016 Dec; 55(12):1425-1433. PubMed ID: 27435662
[TBL] [Abstract][Full Text] [Related]
18. Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastases.
Karamitopoulou E; Zlobec I; Koumarianou A; Patsouris ES; Peros G; Lugli A
Cancer; 2010 Oct; 116(19):4474-86. PubMed ID: 20572035
[TBL] [Abstract][Full Text] [Related]
19. Analyses of 7,635 Patients with Colorectal Cancer Using Independent Training and Validation Cohorts Show That rs9929218 in CDH1 Is a Prognostic Marker of Survival.
Smith CG; Fisher D; Harris R; Maughan TS; Phipps AI; Richman S; Seymour M; Tomlinson I; Rosmarin D; Kerr D; Chan AT; Peters U; Newcomb PA; Idziaszczyk S; West H; Meade A; Kaplan R; Cheadle JP
Clin Cancer Res; 2015 Aug; 21(15):3453-61. PubMed ID: 25873087
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
